We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

GE Healthcare Launches Human Fab Capture Kit

Read time: Less than a minute
GE Healthcare announces the launch of the Human Fab Capture Kit for screening and characterization of human Fab antibody fragments with Biacore™ instruments. The kit is suitable for use with samples including crude cell lysates, periplasmic extracts or purified Fab fragments.

The selection of the Fab fragments is ensured by a broad specificity for human Fab fragments, combined with a high capture efficiency and stability, providing assay performance.

The pre-optimized assay for this kit delivers resource and time savings as it eliminates the need to find and identify suitable reagents, and minimizes assay development and verification. In addition, there is only a minimal need for adjustments between projects due to antigen-independent immobilization and regeneration conditions.

The Human Fab Capture Kit contains Human Fab Binder and immobilization buffer for 10 immobilizations and regeneration solution for 1000 regeneration injections when used with Biacore T100 and Biacore A100.